Clinical Trials · NCT00439244
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novartis
- Enrollment
- 412
- Start date
- Dec 2006
- Locations
- 33 sites, 4 countries
- Primary endpoint
- Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Week 52